Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero (Q34461381)

2 August 2017

1 reference

title

Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero (English)

1 reference

2 August 2017

4

Caroline Tiemessen

1 reference

2 August 2017

3

Glenda Gray

1 reference

2 August 2017

Stephen Meddows-Taylor

object named as

Stephen Meddows-Taylor

series ordinal

2

0 references

Louise Kuhn

series ordinal

1

object named as

Louise Kuhn

1 reference

2 August 2017

language of work or name

English

0 references

publication date

7 December 2001

1 reference

Clinical Infectious Diseases

2 August 2017

published in

1 reference

2 August 2017

volume

34

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

267-276

1 reference

Immune responses in HIV-exposed seronegatives: have they repelled the virus?

2 August 2017

cites work

1 reference

Protective immunity against HIV infection: has nature done the experiment for us?

21 January 2018

1 reference

Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers

21 January 2018

1 reference

High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection

21 January 2018

1 reference

T-helper cell responses to HIV envelope peptides in cord blood: protection against intrapartum and breast-feeding transmission

21 January 2018

1 reference

C-C chemokines, pivotal in protection against HIV type 1 infection

21 January 2018

1 reference

CD8 Cell Noncytotoxic Antiviral Activity in Human Immunodeficiency Virus‐Infected and ‐Uninfected Children

21 January 2018

1 reference

Detection of virus in vertically exposed HIV-antibody-negative children

21 January 2018

1 reference

Clearance of HIV infection in a perinatally infected infant

21 January 2018

1 reference

Genetic evaluation of suspected cases of transient HIV-1 infection of infants

21 January 2018

1 reference

Correlation of virus load and soluble L-selectin, a marker of immune activation, in pediatric HIV-1 infection

21 January 2018

1 reference

Transient T cell receptor beta-chain variable region-specific expansions of CD4+ and CD8+ T cells during the early phase of pediatric human immunodeficiency virus infection: characterization of expanded cell populations by T cell receptor phenotypin

21 January 2018

1 reference

Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production

21 January 2018

1 reference

Cytotoxic-T-Cell Responses, Viral Load, and Disease Progression in Early Human Immunodeficiency Virus Type 1 Infection

21 January 2018

1 reference

Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia

21 January 2018

1 reference

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

21 January 2018

1 reference

Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection

21 January 2018

1 reference

Helper T-cell responses in children infected with human immunodeficiency virus type 1

21 January 2018

1 reference

Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease

21 January 2018

1 reference

In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus

21 January 2018

1 reference

Timing of maternal-infant HIV transmission

21 January 2018

1 reference

Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types

21 January 2018

1 reference

T cell multideterminant regions in the human immunodeficiency virus envelope: toward overcoming the problem of major histocompatibility complex restriction

21 January 2018

1 reference

Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide

21 January 2018

1 reference

Timing of mother-to-child HIV-1 transmission and diagnosis of infection based on polymerase chain reaction in the neonatal period by a non-parametric method

21 January 2018

1 reference

Defining the time of fetal or perinatal acquisition of human immunodeficiency virus type 1 infection on the basis of age at first positive culture. Women and Infants Transmission Study (WITS).

21 January 2018

1 reference

Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

21 January 2018

1 reference

Exposure to human immunodeficiency virus (HIV) type I indicated by HIV-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies [corrected]

21 January 2018

1 reference

Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope

21 January 2018

1 reference

Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients

21 January 2018

1 reference

Antigen-driven C–C Chemokine-mediated HIV-1 Suppression by CD4+ T Cells from Exposed Uninfected Individuals Expressing the Wild-type CCR-5 Allele

21 January 2018

1 reference

Quantification of CD8+ T lymphocytes responsive to human immunodeficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative persons at high risk for recent HIV exposure

21 January 2018

1 reference

Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response

21 January 2018

1 reference

Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons

21 January 2018

1 reference

Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects

21 January 2018

1 reference

Factors contributing to the lack of human immunodeficiency virus type 1 (HIV-1) transmission in HIV-1-discordant partners.

21 January 2018

1 reference

Sensitization to human immunodeficiency virus in seronegative exposed partners

21 January 2018

1 reference

Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya

21 January 2018

1 reference

HIV-1-specific cellular immune responses among HIV-1-resistant sex workers

21 January 2018

1 reference

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

21 January 2018

1 reference

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

21 January 2018

1 reference

HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood

21 January 2018

1 reference

ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids

21 January 2018

1 reference

HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers

21 January 2018

1 reference

Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women

21 January 2018

1 reference

Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group

21 January 2018

1 reference

HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi.

21 January 2018

1 reference

Excess intrauterine fetal demise associated with maternal human immunodeficiency virus infection.

21 January 2018

1 reference

Maternofetal transmission of AIDS: frequency of human immunodeficiency virus type 1 nucleic acid sequences in human fetal DNA

21 January 2018

1 reference

Human Immunodeficiency Virus Type 1 Infection of Human Placental Macrophages In Vitro

21 January 2018

1 reference

Selection of maternal human immunodeficiency virus type 1 variants in human placenta. European Network for In Utero Transmission of HIV-1.

21 January 2018

1 reference

Presence of human immunodeficiency virus (HIV) type 1 and HIV-1-specific antibodies in cervicovaginal secretions of infected mothers and in the gastric aspirates of their infants

21 January 2018

1 reference

Intrapartum mucosal exposure to human immunodeficiency virus type 1 (HIV-1) of infants born to HIV-1-infected mothers correlates with maternal plasma virus burden.

21 January 2018

1 reference

Frequent detection of HIV-1 in the gastric aspirates of neonates born to HIV-infected mothers

21 January 2018

1 reference

Exposure to HIV-1 during delivery and mother-to-child transmission

21 January 2018

1 reference

Mother‐Child Class I HLA Concordance Increases Perinatal Human Immunodeficiency Virus Type 1 Transmission

21 January 2018

1 reference

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G

21 January 2018

1 reference

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

Reduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmission

21 January 2018

1 reference

Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses

21 January 2018

1 reference

Immune control of HIV-1 after early treatment of acute infection

21 January 2018

1 reference

Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption

21 January 2018

1 reference

Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy

21 January 2018

1 reference

Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages.

21 January 2018

1 reference

Analysis of the cytokine production by cord and adult blood

21 January 2018

1 reference

T-cell function in newborn mice and humans

21 January 2018

1 reference

Induction of protective CTL responses in newborn mice by a murine retrovirus

21 January 2018

1 reference

Demonstration of human T lymphotropic virus type I (HTLV-I)-specific T cell responses from seronegative and polymerase chain reaction-negative persons exposed to HTLV-I.

21 January 2018

1 reference

Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons

21 January 2018

1 reference

Lymphocyte Reactivity to Hepatitis C Virus (HCV) Antigens Shows Evidence for Exposure to HCV in HCV‐Seronegative Spouses of HCV‐Infected Patients

21 January 2018

1 reference

Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women

21 January 2018

1 reference

Interferon-Gamma and Interleukin-10 Production Among HIV-1–Infected and Uninfected Infants of HIV-1–Infected Mothers

21 January 2018

1 reference

Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals

21 January 2018

1 reference

HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals

21 January 2018

1 reference

Effect of Zidovudine Postexposure Prophylaxis on the Development of HIV-Specific Cytotoxic T-Lymphocyte Responses in HIV-Exposed Healthcare Workers

21 January 2018

1 reference

Lymphoproliferative Responses to Recombinant HIV‐1 Envelope Antigens in Neonates and Infants Receiving gp120 Vaccines

21 January 2018

1 reference

Role of Cellular Immunity in Protection against HIV Infection**This article was accepted for publication on 31 October 1996

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/338153

1 reference

2 August 2017

1 reference